| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4167252
Max Phase: Preclinical
Molecular Formula: C26H19N3O2S
Molecular Weight: 437.52
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C1/C(=N\C(=S)NCc2cc3ccccc3cc2O)c2ccccc2N1c1ccccc1
Standard InChI: InChI=1S/C26H19N3O2S/c30-23-15-18-9-5-4-8-17(18)14-19(23)16-27-26(32)28-24-21-12-6-7-13-22(21)29(25(24)31)20-10-2-1-3-11-20/h1-15,30H,16H2,(H,27,32)/b28-24-
Standard InChI Key: XVYVZHGKBZAHPX-COOPMVRXSA-N
Associated Targets(Human)
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 437.52 | Molecular Weight (Monoisotopic): 437.1198 | AlogP: 5.09 | #Rotatable Bonds: 3 |
| Polar Surface Area: 64.93 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 9.00 | CX Basic pKa: | CX LogP: 5.21 | CX LogD: 5.20 |
| Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.44 | Np Likeness Score: -0.73 |
References
| 1. Manikandan A, Moharil P, Sathishkumar M, Muñoz-Garay C, Sivakumar A.. (2017) Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential., 141 [PMID:29032034] [10.1016/j.ejmech.2017.09.076] |
Source
Source(1):